Lenvatinib plus Pembrolizumab in Previously Treated Advanced Endometrial Cancer: 5-Year Outcomes from the Randomized, Phase 3 Study 309/Keynote-775

AuthID
P-01B-AZB
30
Author(s)
Makker, V
·
Colombo, N
·
Casado, A
·
Santin, AD
·
Colomba, E
·
Fujiwara, K
·
Pignata, S
·
Yonemori, K
·
Kim, YM
·
[+10]·
Martínez Rodríguez, JL
·
Arik, Z
·
Arican, A
·
Sebastianelli, A
·
Yu, Z
·
McKenzie, J
·
Kruger, S
·
Meng, R
·
Okpara, CE
·
Lorusso, D
Document Type
Article
Year published
2026
Published
in Journal for ImmunoTherapy of Cancer
Volume: 14, Issue: 2, Pages: e013713
Indexing
Publication Identifiers
Export Publication Metadata
Marked List
Info
At this moment we don't have any links to full text documens.
Name Order Name   Name Order Name   Name Order Name
1 Makker, V;   2 Colombo, N;   3 Casado, A;
4 Santin, AD;   5 Colomba, E;   6 Miller, DS;
7 Fujiwara, K;   8 Pignata, S;   9 Yonemori, K;
10 Kim, YM;   11 Baron-Hay, S;   12 Ray-Coquard, I;
13 Shapira-Frommer, R;   14 Kristeleit, R;   15 Nishio, S;
16 Suzuki, S;   17 Guerra Alía, EM;   18 Sanli, UA;
19 Selle, F;   20 Shikama, A;   21 Martínez Rodríguez, JL;
22 Arik, Z;   23 Arican, A;   24 Sebastianelli, A;
25 Yu, Z;   26 McKenzie, J;   27 Kruger, S;
28 Meng, R;   29 Okpara, CE;   30 Lorusso, D;